DOI: 10.1055/s-00000030

Der Klinikarzt

References

Vinayak S, Schwartzberg LS, Mita MM. et al.
TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.
J Clin Oncol. 2018
36. (suppl; abstr 1011)

Download Bibliographical Data

Search in: